We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock

Delisted

FRTX was delisted on the 18th of December, 2023.

49 hedge funds and large institutions have $14.4M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more call options, than puts

Call options by funds: $31K | Put options by funds: $9K

16% less funds holding

Funds holding: 5849 (-9)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

36% less capital invested

Capital invested by funds: $22.5M → $14.4M (-$8.04M)

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
49
Holders Change
-9
Holders Change %
-15.52%
% of All Funds
1.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
11
Reduced
14
Closed
11
Calls
$31K
Puts
$9K
Net Calls
+$22K
Net Calls Change
-$138K
Name Holding Trade Value Shares
Change
Change in
Stake
ARTA
51
A.R.T. Advisors
New York
-$43K -20 Closed
EWM
52
Evercore Wealth Management
New York
-$18K -8 Closed
CS
53
Credit Suisse
Switzerland
-$8K -4 Closed
JIC
54
Joel Isaacson & Co
New York
-$8K -4 Closed
Millennium Management
55
Millennium Management
New York
-$9K -4 Closed
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
-$7.72K -4 Closed
Citadel Advisors
57
Citadel Advisors
Florida
-$6K -3 Closed
JG
58
Jefferies Group
New York
-$4K -2 Closed
Simplex Trading
59
Simplex Trading
Illinois
-$3.86K -2 Closed
AIG
60
American International Group
New York
-$2.8K -1 Closed
US Bancorp
61
US Bancorp
Minnesota
-$1K

FRTX Hedge Fund Activity: Q3 2015 in Review

49 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q3 2015, worth a combined $14.4M — down 36% from $22.5M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FRTX and 2 opened new positions — a net loss of 9 holders — while 14 trimmed existing stakes and 11 added.

The largest buyer was Fidelity Investments, adding an estimated $743K. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $1.28M sold.

  • 49 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q3 2015, down from 58 in Q2 2015.
  • Funds reported $14.4M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q3 2015, down 36% quarter-over-quarter.
  • 2 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q3 2015 and 11 closed out, a net change of -9 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q3 2015 was Fidelity Investments, an estimated $743K added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q3 2015 was Rock Springs Capital Management, an estimated $1.28M sold.

Based on aggregated 13F filings for Q3 2015.